Please Sign In or Create an account
Increasing chlamydia testing in general practice is achievable: an update from the Australian Chlamydia Control Effectiveness Pilot (ACCEPt)

Increasing chlamydia testing in general practice is achievable: an update from the Australian Chlamydia Control Effectiveness Pilot (ACCEPt)

Methods: From July 2010-December 2011, we enrolled 787 GPs in 150 clinics (response rate >90%) in 54 towns. Chlamydia testing rates (the proportion who consult a GP and have a test during 12 months) and re-testing rates (proportion who are re-tested within 12 (┬▒3) months following a negative or within 3 months following a positive test) were calculated.

Results: We analysed a total of 23,976 tests in intervention and 17,363 in control clinics. Prior to commencing the trial in 2010, chlamydia testing rates were 10.2% in intervention clinics and 8.4% in control clinics. In 2012, testing rates were highest in clinics with 18+ months intervention time at 26.8% in women, 15.1% in men and 22.5% overall, compared with a testing rate of 10.3% in control clinics (relative risk=2.1; 95%CI: 2.0, 2.2). In 2012, chlamydia test positivity was 7.6% in intervention clinics and 8.7% in control clinics (p<0.01). Re-testing following a positive diagnosis was similar between intervention and control clinics (36.4% versus 33.9%; p=0.17). Re-testing after a negative test was higher in intervention clinics, but only slightly (20.5% versus 19.1%l (p<0.01).

Conclusions: Testing rates are increasing in intervention clinics while remaining relatively constant in control clinics showing that a multifaceted intervention in general practice can increase chlamydia testing rates over time. Further efforts are needed to increase re-testing after a positive and a negative test.

Speakers: Anna Wood
Areas of Interest / Categories: Australian Society for HIV 2015

Australian Society for HIV 2015

HIV and Hodgkin's lymphoma - a medical dilemma

The case is of a 30 year-old HIV positive Zimbabwean woman (UK resident) who arrived in Australia in January 2011 on a one-year working visa. She was diagnosed with HIV in 2003 in the UK and commenced on Atripla® in 2005. She was first seen in Adelaide in May 2011, requesting a script for Atripla.®.

High Resolution Anoscopy - Practice makes perfect

Background: Liquid based anal Papanicolaou smears, followed by High Resolution Anoscopy (HRA) guided biopsies are increasingly being advocated to identify areas of High Grade Anal Intraepithelial Neoplasia (HGAIN). We hypothesized that the ability to identify HGAIN would increase with experience of the anoscopist, and that comparison with contemporary Papanicolaou smears might yield insights into technical abilities.

An Indigenous cultural appropriateness audit piloted in a sexual health clinic in NSW: making Aboriginal and Torres Strait Islander peoples a priority.

Indigenous Australians experience a greater burden of sexually transmitted infections, however are less likely than the general population to access sexual health services. We examined the effectiveness of an Indigenous cultural appropriateness audit in assessing a sexual health clinic with low rates of Indigenous clients.

Chlamydia and the Urban Aboriginal Medical Service

Despite the high proportion of young people annually accessing general practices, including Aboriginal Medical Services (AMS), testing for Chlamydia trachomatis remains relatively low in urban areas. A project officer was employed within the Institute of Urban Indigenous Health (IUIH) to serve a mentoring and facilitation role for the SE Queensland network of AMS and their sexual health workers, with a view to improving testing, management and follow-up of chlamydia and other STIs by community controlled medical services.

An optimised eight-colour flow cytometry protocol for the analysis of monocyte heterogeneity and monocyte activation markers during HIV infection.

Monocytes are a heterogeneous cell population having specialised functions and differing phenotype. They are a link between innate immune system and adaptive immune system therefore, to identify if immune activation exists in HIV-1 individuals with controlled virema and recovered CD4 T cell counts, we assessed cell surface monocyte activation markers (MAM) within the monocyte subsets.

The Ask Share Know Project: a research translation study of three consumer questions to enhance treatment decision making

Involving consumers in healthcare decisions is important for high quality care. We previously tested a brief, consumer-led intervention consisting of three questions in a trial employing trained, standardized patients. The intervention enhanced discussion of evidence and increased patient involvement. We now report a research translation study which tested implementation with real patients at a reproductive and sexual health clinic.

Combination prevention with confidence?: A review of where community HIV health promotion evaluation is most, moderately and least developed